Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H14N2O5 |
Molecular Weight | 242.2286 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O
InChI
InChIKey=IQFYYKKMVGJFEH-CSMHCCOUSA-N
InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1
Molecular Formula | C10H14N2O5 |
Molecular Weight | 242.2286 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:21:09 UTC 2023
by
admin
on
Sat Dec 16 16:21:09 UTC 2023
|
Record UNII |
2OC4HKD3SF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548766
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NCI_THESAURUS |
C97452
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NDF-RT |
N0000175656
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NDF-RT |
N0000009947
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
WHO-ATC |
J05AF11
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SEBIVO (AUTHORIZED: HEPATITIS B, CHRONIC)
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
WHO-VATC |
QJ05AF11
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66584
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
DB01265
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
3424-98-4
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
2OC4HKD3SF
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
Telbivudine
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
DTXSID30187813
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
159269
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
63624
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
TELBIVUDINE
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
SUB25231
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
CHEMBL374731
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
MM-30
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
474128
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | RxNorm | ||
|
4220
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
100000089257
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
m10528
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | Merck Index | ||
|
8296
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY | |||
|
C487779
Created by
admin on Sat Dec 16 16:21:09 UTC 2023 , Edited by admin on Sat Dec 16 16:21:09 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
URINE
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
FECAL
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET ORGANISM->INHIBITOR |
EC50
|
||
|
TRANSPORTER -> NON-SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||